Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Dendreon Corp (NQ: DNDN)
3.890 USD  -0.020 (-0.51%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Dendreon Corp
 
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Commit To Buy Dendreon At $2, Earn 26.5%
May 23, 2013
Investors eyeing a purchase of Dendreon Corp (DNDN) shares, but tentative about paying the going market price of $3.92/share, might benefit from considering selling puts among the alternative... Read More
category Stocks
from Market News Video
Commit To Buy Dendreon At $2, Earn 26.5%
May 23, 2013
Investors eyeing a purchase of Dendreon Corp (DNDN) shares, but tentative about paying the going market price of $3.92/share, might benefit from considering selling puts among the alternative... Read More
category Dividends
from Dividend Channel
Neuralstem Phase I Results Encourage Market, Stimulates Buying
May 21, 2013
Although it seems that investors have lost their appetite for many stem cell investments at this stage of the broader rally in the stock market, there are exceptions worth pointing out. Neuralstem... Read More
category Bio/Wire , CUR
from Bio-Wire.Com
Supernus Shorts See Losses, Dendreon Shorts Extend Gains
May 20, 2013
Two companies with extremely high short interest as of April 30th – Dendreon Corporation (NASDAQ: DNDN) and Supernus Pharmaceuticals (NASDAQ: SUPN) at 35.4% and 36% of shares short as percentage of... Read More
category SUPN , Bio/Wire , DNDN
from Bio-Wire.Com
Three of WellPoint's directors resign for personal reasons
May 13, 2013
May 13 (Reuters) - Health insurer WellPoint Inc said three of its directors resigned, effective immediately, citing personal reasons. Read More
category companyNews
from Reuters: Company News
Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
May 13, 2013
category Pharmaceuticals
from Trefis
Highlights on Block Activity and Options Trading for Dendreon
May 13, 2013
NEW YORK (AVAFIN) -- Financial institutions traded 42 block trades on shares of Dendreon. ... Read More
from AVAFIN
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Closing Bell for Friday on Wall Street: Markets Open Mixed, Close Higher
May 10, 2013
DailyFinance.com : U.S. equity markets opened mixed this morning and failed to find a direction driver throughout the trading day. In Europe, Germany reported a stronger-than-expected trade surplus,... Read More
category dndn , ba , wcrx , and 13 more.
from DailyFinance.com
Notable Analyst Rating Changes 05/10: (FST) (EIX) (BSX) Upgraded; (MDR) (DNDN) (LTD) Downgraded
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326447 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Bank of America Lowers PT on Dendreon Following 1Q13 Miss, Increased Risks
May 10, 2013
In a report published Friday, Bank of America analyst Rachel McMinn reiterated an Underperform rating on Dendreon Corporation (NASDAQ: DNDN ), and lowered the price target from $5.00 to $1.00. In the... Read More
category Benzinga , Bank of America , Price Target , and 3 more.
from Latest Articles from Benzinga.com
Dendreon (DNDN) Q1/13 Results, Pricing the therapy is still the “electronic” collar on this dog’s neck – SELL
May 10, 2013
Net loss of $72 million, or $0.48 per share   Net loss was $72 million or $0.48 per share, compared to $103.9 million, or $0.70 per share for Q1/2012. The decrease in net loss for the 2013 is primarily... Read More
category Henry McCusker
from Bio-Wire.Com
Citi Downgrades Dendreon (DNDN) to Sell
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8325611 for the full story. Read More
from StreetInsider.com News Articles
Roth Capital Downgrades Dendreon (DNDN) to Sell
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8322709 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Stifel Nicolaus Downgrades Dendreon (DNDN) to Sell
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8322585 for the full story. Read More
from StreetInsider.com News Articles
Mid-Day Market Update: Precision Castparts Rises as Rackspace Plummets
May 09, 2013
Midway through trading Thursday, the Dow traded down 0.01 percent to 15,104.07 while the NASDAQ rose 0.05 percent to 3,414.18. The S&P also fell, decreasing 0.19 percent to 1,629.25. Top Headline Tesla... Read More
category Earnings , Benzinga , Movers , and 19 more.
from Latest Articles from Benzinga.com
Mid-Morning Market Update: Tesla Soars on Earnings as LivePerson Gets Crushed
May 09, 2013
Following the market opening Thursday, the Dow traded down 0.09 percent to 15,092.07 while the NASDAQ fell 0.07 percent to 3,411.18. The S&P also fell, decreasing 0.23 percent to 1,628.25. Top Headline... Read More
category Earnings , Benzinga , Movers , and 18 more.
from Latest Articles from Benzinga.com
Markets Retreat After Yesterday's Record Close
May 09, 2013
Jobless claims unexpectedly dropped to a five year low but the markets opened lower with the Dow losing 25 points to 15,079 after a record close yesterday. Nasdaq slipped 6 points to 3407. Read More
category Market News
from MarketMinute.com Market Updates
UPDATE 2-Dendreon's cancer vaccine sales drop as competition heats up
May 09, 2013
* Co says competition, lack of patient access caused sales decline Read More
category companyNews
from Reuters: Company News
Dendreon Shocks Market With PROVENGE Sales Decline In Q1 2013
May 09, 2013
Today Dendreon (NASDAQ: DNDN) shocked the market after reporting an extremely disappointing $67.6 M in PROVENGE (sipuleucel-T) sales for Q1 2013, representing a 17.56% decline relative to $82 M in... Read More
category Bio/Wire , DNDN
from Bio-Wire.Com
Dendreon Corp (DNDN) Reports In-Line Q1 Loss of 48c/Share
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8321026 for the full story. Read More
from StreetInsider.com News Articles
Dendreon Corp (DNDN) halted, news pending
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8320934 for the full story. Read More
from StreetInsider.com News Articles
Dendreon (DNDN) - Market Digest
May 09, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading options contracts during the market ... Read More
from AVAFIN
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8318004 for the full story. Read More
from StreetInsider.com News Articles
StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, and MDVN
May 08, 2013
from ACCESSWIRE
Bracing for Dendreon Q1 2013 Earnings – All Eyes On PROVENGE
May 08, 2013
Today, Dendreon (NASDAQ: DNDN) shareholders will brace for the company’s Q1 2013 earnings, which will be discussed in a conference call on Thursday at 9:00 AM EDT. Dendreon, which has been operating at... Read More
category Bio/Wire , DNDN
from Bio-Wire.Com
The Week Ahead: Host of Earnings on Tap; Investors Watching Anadarko, Activision, and Whole Foods
May 03, 2013
The upcoming trading week will see a host of companies releasing their quarterly results as earnings season continues in high gear. Investors will also be focused on key economic data set to be... Read More
category Earnings , Benzinga , Global , and 50 more.
from Latest Articles from Benzinga.com
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 34 more.
from Latest Articles from Benzinga.com
Highlights on Options Trading for Dendreon
April 23, 2013
NEW YORK (AVAFIN) -- Unusual volume of DNDN put contracts exchanged hands yesterday ... Read More
from AVAFIN
AVEO Poised To Move Higher Before May 2 FDA Adcomm Catalyst, Obama Care, And Platform Potential
April 15, 2013
category Pharmaceuticals
from Trefis
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here